You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
phar ma ceu ti cal em ploy ees in 2008. Di vi sions<br />
include: OTC (including dietetics).<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 51-100 (2008)<br />
Con tacts (Pharm): Chair man: Teresio Roberto<br />
Bertani; Com mer cial Op er a tions: Massimo<br />
Micheli; Man u fac ture: An to nio Polastri<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 190-200 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 60-65%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
85-90%<br />
Prin ci pal Prod ucts:<br />
VOLTAREN EMULGEL (antirheumatic top i cal)<br />
GAVISCON AD VANCE (ant acid/antiflatulent/car -<br />
mi na tive)<br />
VENORUTON (var i cose ther apy sys temic; var i -<br />
cose ther apy top i cal)<br />
PURSENNID (lax a tive)<br />
VOLTADOL (antirheumatic top i cal)<br />
Ther a peu tic Range:<br />
anti rheu ma tics top i cal 28%<br />
ant ac ids/antiflatulents/antiulcerants 18%<br />
an al ge sics 13%<br />
lax a tives 12%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
10%<br />
Lead ing Dose Forms:<br />
liq uids 27%<br />
gels/sols 24%<br />
coated tab lets 14%<br />
tab lets 11%<br />
pow ders/gran ules 10%<br />
NOVARTIS VAC CINES<br />
Street Ad dress: Bellaria Rosia, 53018 Sovicille<br />
Tel: +39 577 2436 19<br />
Fax: +39 577 2786 00<br />
Home Page: www.novartisvaccines.com<br />
Phar ma ceu ti cal Sales: US$ 35-40 mil lion<br />
Prod ucts (% of Sales by Lead ing 5):<br />
95-100%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): n.a.<br />
Dose Forms (% of Sales by Lead ing 5): n.a.<br />
Prin ci pal Prod ucts:<br />
MENJUGATE (vac cine pure)<br />
AGRIPPAL S1 (vac cine pure)<br />
FLUAD (vac cine pure)<br />
ANATETALL (vac cine pure)<br />
BIOCINE TEST PPD M (di ag nos tic test other)<br />
Ther a peu tic Range:<br />
vac cines 97%<br />
di ag nos tic tests 3%<br />
Lead ing Dose Forms:<br />
pre-filled sy ringes/pens 56%<br />
vi als 30%<br />
am poules 13%<br />
liq uids 1%<br />
SANDOZ<br />
Full Name: Sandoz S.p.A.<br />
Street Ad dress: Largo Umberto Boccioni 1,<br />
21040 Origgio/VA<br />
Tel: +39 02 96 541<br />
Fax: +39 02 96 543496<br />
Home Page: www.sandoz.it<br />
De scrip tion: Sales/detailer. Prod uct ranges in -<br />
clude: phar ma ceu ti cal prod ucts (unbranded, pre -<br />
scrip tion), hos pi tal pharmaceuticals.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 101-500 (2007)<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 75-80 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 30-35%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 50-55%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
90-95%<br />
Prin ci pal Prod ucts:<br />
LANSOPRAZOLO SAN (antiulcerant)<br />
NICERGOLINA SAN (ce re bral/pe riph eral<br />
vasotherapeutic)<br />
AMOX+AC CLAV SAN (pen i cil lin broad spec trum)<br />
CAL CIUM SANDOZ (cal cium prod uct)<br />
CEFTRIAXONE SAN (cephalosporin)<br />
Ther a peu tic Range:<br />
antibacterials sys temic 15%<br />
ant ac ids/antiflatulents/antiulcerants 13%<br />
ce re bral/pe riph eral vasotherapeutics 10%<br />
renin-an gio ten sin sys tem agents 7%<br />
min eral sup ple ments 6%<br />
Lead ing Dose Forms:<br />
tab lets 37%<br />
cap sules 19%<br />
coated tab lets 17%<br />
liq uids 10%<br />
vi als 7%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 181
Change language